40–45% who contract new coronavirus are asymptomatic

A new study warns that around 40–45% of people who contract SARS-CoV-2 most likely remain symptom-free. Such cases may contribute to the “silent spread” of the virus. Moreover, even asymptomatic people may experience long-term respiratory issues, the study authors caution. In considering the spread dynamics of the new coronavirus — or SARS-CoV-2 — researchers, and health authorities have been pondering […]

» Read more

New virus cases in China, N. Zealand sound pandemic alarm

More than two dozen new coronavirus cases in China and the first New Zealand infections in almost a month on Tuesday underlined the immense challenges still ahead in containing the deadly pandemic, even as some EU nations reopened their borders to fellow Europeans. More than eight million people have now been infected with the virus worldwide since it first emerged […]

» Read more

FDA approves video game for treating ADHD in kids

The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD. […]

» Read more

Interoperability groups are evolving, expanding during COVID-19

As it has in so many other areas of the U.S. healthcare system, the coronavirus crisis has highlighted some fundamental challenges with regard to interoperability, data exchange and public health surveillance and reporting. But there have been some bright spots too, as health information exchange organizations have pivoted to meet the unique needs of this moment – and have often […]

» Read more

Delta opioid receptor identified as promising therapeutic target for inflammatory pain relief

Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles—making them a promising target for treating chronic inflammatory pain with fewer side effects, according to a new study from an international team of researchers. The study, published in Proceedings of the National Academy of Sciences (PNAS), was conducted using cells from humans […]

» Read more

COVID-19: Lower risk of death in treatment with medication for heartburn – natural healing naturopathic specialist portal

Study shows potential of heartburn drug for COVID-19 According to an observational study, which was conducted at Irving, Medical Center of Columbia University (USA), could help a common drug for heartburn by the Coronavirus SARS-CoV-2-induced disease COVID-19. In a new study has shown that COVID-19-patients and in -patients in the Famotidine, a common drug for heartburn, and received, a two-fold […]

» Read more

Magnetic guidance improves stem cells’ ability to treat occupational lung disease

Results of a study released today in Stem Cells Translational Medicine (SCTM) may point the way to a cure for a serious lung disease called silicosis that affects millions of workers worldwide. Silicosis results from years of breathing in dust microparticles of silica by workers in professions such as construction and sand blasting. The particles can eventually lead to inflammation […]

» Read more
1 1,225 1,226 1,227 1,228 1,229 1,330